Review article · 2022 · Open access
Small-molecule drugs development for Alzheimer's disease
Frontiers in Aging Neuroscience, 14, 1019412 · Published 1 November 2022 · DOI 10.3389/fnagi.2022.1019412
In brief
“Small-molecule drugs development for Alzheimer's disease” is a 2022 review article by Weiwei Yao and 2 co-authors, published in Frontiers in Aging Neuroscience. OpenAlex counts 55 citations as of 15 November 2026, which puts it in the top 2% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Aging Neuroscience.
- Citations
- 55
- Most cited in
- 2026 (19)
- Field-weighted impact
- 1.02
- References
- 140
- Authors
- 3
Abstract
Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative brain disorder with no effective therapeutic drugs currently. The complicated pathophysiology of AD is not well understood, although beta-amyloid (Aβ) cascade and hyperphosphorylated tau protein were regarded as the two main causes of AD. Other mechanisms, such as oxidative stress, deficiency of central cholinergic neurotransmitters, mitochondrial dysfunction, and inflammation, were also proposed and studied as targets in AD. This review aims to summarize the small-molecule drugs that were developed based on the pathogenesis and gives a deeper understanding of the AD. We hope that it could help scientists find new and better treatments to gradually conquer the problems related to AD in future.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Yao, W., Yang, H., & Yang, J. (2022). Small-molecule drugs development for Alzheimer's disease. Frontiers in Aging Neuroscience, 14, 1019412. https://doi.org/10.3389/fnagi.2022.1019412
MLA 9
Yao, Weiwei, et al. “Small-molecule drugs development for Alzheimer's disease.” Frontiers in Aging Neuroscience, vol. 14, 2022, p. 1019412. https://doi.org/10.3389/fnagi.2022.1019412.
Chicago
Yao, Weiwei, Huihui Yang, and Jinfei Yang. 2022. “Small-molecule drugs development for Alzheimer's disease.” Frontiers in Aging Neuroscience 14: 1019412. https://doi.org/10.3389/fnagi.2022.1019412.
Harvard
Yao, W., Yang, H. and Yang, J. (2022) ‘Small-molecule drugs development for Alzheimer's disease’, Frontiers in Aging Neuroscience, 14, p. 1019412. doi:10.3389/fnagi.2022.1019412.
IEEE
W. Yao, H. Yang, and J. Yang, “Small-molecule drugs development for Alzheimer's disease,” Frontiers in Aging Neuroscience, vol. 14, p. 1019412, 2022, doi: 10.3389/fnagi.2022.1019412.
BibTeX
@article{yao2022small,
title = {{Small-molecule drugs development for Alzheimer's disease}},
author = {Yao, Weiwei and Yang, Huihui and Yang, Jinfei},
journal = {Frontiers in Aging Neuroscience},
year = {2022},
volume = {14},
pages = {1019412},
doi = {10.3389/fnagi.2022.1019412},
url = {https://doi.org/10.3389/fnagi.2022.1019412}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 6 | |
| 2024 | 17 | |
| 2025 | 13 | |
| 2026 | 19 |
Its field-weighted citation impact is 1.02: it has been cited 1.02 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Alzheimer's disease
- small molecule drugs
- drug development
- amyloid-beta
- tau hyperphosphorylation
- oxidative stress
- cholinergic neurotransmitters
- mitochondrial dysfunction
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Yao, W., Yang, H., & Yang, J. (2022). Small-molecule drugs development for Alzheimer's disease. Frontiers in Aging Neuroscience, 14, 1019412. https://doi.org/10.3389/fnagi.2022.1019412
How many times has this paper been cited?
55 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Frontiers in Aging Neuroscience.
Who wrote this paper?
Weiwei Yao, Huihui Yang, Jinfei Yang.
What is the DOI of this paper?
10.3389/fnagi.2022.1019412. The permanent link is https://doi.org/10.3389/fnagi.2022.1019412.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.